Acerinox (ACX) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
27 Feb, 2026Executive summary
Net sales rose 7% year-over-year to €5.78 billion, with adjusted EBITDA at €422 million, despite a challenging macroeconomic environment, low demand, and tariff tensions.
EBITDA margin declined to 6% from 9% in 2024, with reported EBITDA at €354 million after €69 million in year-end adjustments.
Operating cash flow surged 55% to €455 million, driven by a €406 million reduction in working capital.
Net financial debt increased by €68 million to €1.189 billion, mainly due to investments, dividends, and FX impacts.
Haynes International was fully integrated, contributing to diversification and €12 million in synergies.
Financial highlights
Adjusted EBITDA for 2025 was €422 million; reported EBITDA was €354 million after €69 million in year-end adjustments.
Net sales grew 7% year-over-year to €5.78 billion.
Operating cash flow reached €455 million, driven by a €406 million reduction in working capital, mainly from inventory reductions.
CAPEX totaled €311 million, focused on strategic projects and modernization.
Dividend payout totaled €155 million (€0.62/share).
Outlook and guidance
Positive outlook for 2026, expecting gradual EBITDA recovery, especially in the second half as new European trade measures take effect.
Q1 2026 adjusted EBITDA is expected to be slightly higher than Q4 2025.
Market normalization expected as inventory levels remain low and new trade defense measures support local producers.
Latest events from Acerinox
- Q2 EBITDA of €125M and net debt reduction show resilience despite market and strike challenges.ACX
Q2 20243 Feb 2026 - Q3 EBITDA was €114 million; Bahru sale and Haynes deal to lift Q4 amid weak demand.ACX
Q3 202418 Jan 2026 - 2024 marked transformation with Haynes acquisition, Bahru sale, and resilient financials.ACX
Q4 202415 Dec 2025 - Strategic investments and sustainability drive future growth as all AGM proposals are approved.ACX
AGM 202519 Nov 2025 - Q1 EBITDA reached €102M with strong cash flow and Q2 outlook improving.ACX
Q1 202519 Nov 2025 - Q2 EBITDA up 10% sequentially, but H1 profit fell on European weakness and tax impairment.ACX
Q2 202513 Nov 2025 - Q3 EBITDA €108M, cash flow strong, but demand weak; Q4 outlook cautious amid market headwinds.ACX
Q3 20253 Nov 2025